1. Home
  2. BRC vs PBLS Comparison

BRC vs PBLS Comparison

Compare BRC & PBLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brady Corporation

BRC

Brady Corporation

HOLD

Current Price

$93.17

Market Cap

4.1B

ML Signal

HOLD

PBLS

Parabilis Medicines Inc. Common Stock

N/A

Current Price

$28.81

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BRC
PBLS
Founded
1914
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.4B
IPO Year
2005
2026

Fundamental Metrics

Financial Performance
Metric
BRC
PBLS
Price
$93.17
$28.81
Analyst Decision
Hold
Analyst Count
1
0
Target Price
$1.20
N/A
AVG Volume (30 Days)
232.3K
545.1K
Earning Date
05-15-2026
N/A
Dividend Yield
1.20%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,144,698,000.00
N/A
Revenue This Year
$7.36
N/A
Revenue Next Year
$3.57
N/A
P/E Ratio
$23.35
N/A
Revenue Growth
5.86
N/A
52 Week Low
$68.11
$25.56
52 Week High
$99.29
$33.65

Technical Indicators

Market Signals
Indicator
BRC
PBLS
Relative Strength Index (RSI) 64.56 52.17
Support Level $88.79 $26.96
Resistance Level $95.87 $30.90
Average True Range (ATR) 2.30 2.39
MACD 0.09 -0.05
Stochastic Oscillator 63.71 30.56

Price Performance

Historical Comparison
BRC
PBLS

About BRC Brady Corporation

Brady Corp provides identification solutions and workplace safety products. The company offers identification and healthcare products that are sold under the Brady brand to maintenance, repair, and operations as well as original equipment manufacturing customers. Products include safety signs and labeling systems, material identification systems, wire identification, patient identification, and people identification. Brady also provides workplace safety and compliance products such as safety and compliance signs, asset tracking labels, and first-aid products. The company is organized and managed on a geographic basis with two reportable segments: Americas & Asia which derives maximum revenue, and Europe & Australia.

About PBLS Parabilis Medicines Inc. Common Stock

Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Share on Social Networks: